Ovarian and Gynecologic Cancer Translational Research Disease Group

Understanding the genetic alterations that lead to ovarian and gynecologic cancer is essential to fighting the disease. At Fox Chase, a multidisciplinary team of researchers and clinicians meets regularly to review translational research initiatives to identify and characterize new biomarkers of ovarian and gynecologic cancers that lead to new, innovative prevention and targeted therapy options for our patients.